Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants.
Mäkelä AR, Uğurlu H, Hannula L, Kant R, Salminen P, Fagerlund R, Mäki S, Haveri A, Strandin T, Kareinen L, Hepojoki J, Kuivanen S, Levanov L, Pasternack A, Naves RA, Ritvos O, Österlund P, Sironen T, Vapalahti O, Kipar A, Huiskonen JT, Rissanen I, Saksela K. Mäkelä AR, et al. Among authors: ugurlu h. Nat Commun. 2023 Mar 24;14(1):1637. doi: 10.1038/s41467-023-37290-6. Nat Commun. 2023. PMID: 36964125 Free PMC article.
SARS-CoV-2 and type 1 diabetes in children in Finland: an observational study.
Knip M, Parviainen A, Turtinen M, But A, Härkönen T, Hepojoki J, Sironen T, Iheozor-Ejiofor R, Uğurlu H, Saksela K, Lempainen J, Ilonen J, Vapalahti O; Finnish Pediatric Diabetes Register. Knip M, et al. Among authors: ugurlu h. Lancet Diabetes Endocrinol. 2023 Apr;11(4):251-260. doi: 10.1016/S2213-8587(23)00041-4. Lancet Diabetes Endocrinol. 2023. PMID: 36958868
Intranasal administration of adenoviral vaccines expressing SARS-CoV-2 spike protein improves vaccine immunity in mouse models.
Freitag TL, Fagerlund R, Karam NL, Leppänen VM, Ugurlu H, Kant R, Mäkinen P, Tawfek A, Jha SK, Strandin T, Leskinen K, Hepojoki J, Kesti T, Kareinen L, Kuivanen S, Koivulehto E, Sormunen A, Laidinen S, Khattab A, Saavalainen P, Meri S, Kipar A, Sironen T, Vapalahti O, Alitalo K, Ylä-Herttuala S, Saksela K. Freitag TL, et al. Among authors: ugurlu h. Vaccine. 2023 May 11;41(20):3233-3246. doi: 10.1016/j.vaccine.2023.04.020. Epub 2023 Apr 14. Vaccine. 2023. PMID: 37085458 Free PMC article.
Double-blinded, randomised, placebo-controlled trial of convalescent plasma for COVID-19: analyses by neutralising antibodies homologous to recipients' variants.
Khawaja T, Kajova M, Levonen I, Pietilä JP, Välimaa H, Paajanen J, Pakkanen SH, Patjas A, Montonen R, Miettinen S, Virtanen J, Smura T, Sironen T, Fagerlund R, Ugurlu H, Iheozor-Ejiofor R, Saksela K, Vahlberg T, Ranki A, Vierikko A, Ihalainen J, Vapalahti O, Kantele A. Khawaja T, et al. Among authors: ugurlu h. Infect Dis (Lond). 2024 Jun;56(6):423-433. doi: 10.1080/23744235.2024.2329957. Epub 2024 Mar 21. Infect Dis (Lond). 2024. PMID: 38513074
Correlation of clinical signs and magnetic resonance imaging findings in patients with lumbar spondylosis.
Altan L, Metin Ökmen B, Tuncer T, Sindel D, Fatih Çay H, Hepgüler S, Sarıkaya S, Ayhan F, Bal A, Bilgilisoy M, Çapkın E, Cerrahoğlu L, Çevik R, Dülgeroğlu D, Durmaz B, Duruöz T, Gürer G, Gürsoy S, Hizmetli S, Kaçar C, Kaptanoğlu E, Ecesoy H, Melikoğlu M, Nas K, Nur H, Özçakır Ş, Şahin N, Şahin Ö, Sarıdoğan M, Faruk Şendur Ö, Sezer İ, Taşçı Bozbaş G, Tıkız C, Uğurlu H. Altan L, et al. Among authors: ugurlu h. Arch Rheumatol. 2023 Feb 15;38(4):512-520. doi: 10.46497/ArchRheumatol.2023.9806. eCollection 2023 Dec. Arch Rheumatol. 2023. PMID: 38125064 Free PMC article.
46 results